Neuroblastoma Journal Article


Authors: Kushner, B. H.; Cheung, N. K.
Article Title: Neuroblastoma
Abstract: The identification of prognostic factors has greatly facilitated the rational choice of therapies in individual patients. Intensive chemotherapy, supplemented with radiation and surgery, has increased the remission rate of patients with widespread disease. The persistence of microscopic foci of malignant cells, however, remains a difficult hurdle for long-term disease-free survival. Highly toxic myeloablative therapies have had at most a modest impact on the overall cure rate of poor-risk patients. The use of novel biological therapies has provided new information on the mechanisms and potentials of immune-mediated tumor cytotoxicity. Timely clinical trials are needed to test their role in adjuvant treatment of occult microscopic disease.
Keywords: review; multimodality cancer therapy; antineoplastic agents; combined modality therapy; antineoplastic agent; pathology; infant; neuroblastoma; human
Journal Title: Pediatric Annals
Volume: 17
Issue: 4
ISSN: 0090-4481
Publisher: SLACK, Inc.  
Date Published: 1988-04-01
Start Page: 269
End Page: 276, 278-284
Language: English
PUBMED: 3290814
PROVIDER: scopus
DOI: 10.3928/0090-4481-19880401-07
DOI/URL:
Notes: Review -- Export Date: 6 August 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Brian Kushner
    311 Kushner
  2. Nai-Kong Cheung
    648 Cheung